Chardan Capital Issues Positive Forecast for Hyperion DeFi (NASDAQ:HYPD) Stock Price

Hyperion DeFi (NASDAQ:HYPD) had its price objective increased by analysts at Chardan Capital from $7.30 to $8.45 in a research note issued on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Chardan Capital’s price target would suggest a potential upside of 132.97% from the stock’s previous close.

HYPD has been the subject of several other research reports. Zacks Research lowered Hyperion DeFi from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 12th. Weiss Ratings raised Hyperion DeFi from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, September 1st. Finally, Cantor Fitzgerald raised their price target on Hyperion DeFi from $6.60 to $7.10 and gave the stock an “overweight” rating in a report on Thursday, August 13th. Two research analysts have rated the stock with a Buy rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Hyperion DeFi presently has a consensus rating of “Hold” and an average price target of $7.77.

Hyperion DeFi Stock Up 9.9%

Shares of Hyperion DeFi stock traded up $0.33 on Tuesday, reaching $3.63. The stock had a trading volume of 884,686 shares, compared to its average volume of 460,093. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $56.36 million, a P/E ratio of -0.54 and a beta of 2.53. The company has a 50 day moving average price of $2.93 and a 200 day moving average price of $3.28. Hyperion DeFi has a 1 year low of $2.34 and a 1 year high of $15.00.

Hyperion DeFi (NASDAQ:HYPD) last posted its earnings results on Thursday, August 13th. The company reported $0.92 EPS for the quarter. The company had revenue of $0.36 million during the quarter. Hyperion DeFi had a net margin of 416.56% and a negative return on equity of 11.62%. As a group, equities research analysts forecast that Hyperion DeFi will post 1.78 EPS for the current year.

Hedge Funds Weigh In On Hyperion DeFi

Hedge funds have recently made changes to their positions in the company. Sanctuary Advisors LLC acquired a new stake in Hyperion DeFi during the 4th quarter worth about $38,000. Investment House LLC acquired a new position in shares of Hyperion DeFi in the fourth quarter valued at about $166,000. Geode Capital Management LLC purchased a new position in shares of Hyperion DeFi in the fourth quarter worth about $214,000. Focus Partners Advisor Solutions LLC purchased a new position in shares of Hyperion DeFi in the fourth quarter worth about $221,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Hyperion DeFi during the fourth quarter worth about $663,000. 25.84% of the stock is owned by institutional investors and hedge funds.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.